What is Jianke?
方舟健客 (Jianke) operates as a certified online pharmacy, committed to delivering high-quality, accessible, and convenient health services. The platform boasts an extensive catalog of products, encompassing prescription medications for a spectrum of health conditions, essential medical devices, and health supplements. Jianke primarily targets individuals seeking dependable health solutions, with a particular focus on men's health, dermatological care, and the management of chronic diseases. The company's overarching mission is to establish itself as a trusted health service provider, ensuring customer satisfaction through professional advice and dedicated support.
How much funding has Jianke raised?
Jianke has raised a total of $180M across 2 funding rounds:
Series A
$50M
Series B
$130M
Series A (2017): $50M, investors not publicly disclosed
Series B (2018): $130M, investors not publicly disclosed
What's next for Jianke?
The substantial enterprise-level capital infusion positions Jianke for accelerated expansion and enhanced service offerings. Following its recent strategic investment, the company is poised to further solidify its market presence, potentially through technological advancements, broader product diversification, or strategic partnerships. This financing is indicative of Jianke's strong market validation and its capacity to scale operations effectively within the competitive online healthcare landscape.
See full Jianke company page
